Top Markets
Coin of the day
Citius Oncology, Inc. Citius Oncology, Inc.

Citius Oncology, Inc.

CTOR
Ранг среди акций #23802
Citius Oncology, Inc. concentrates on advancing innovative, targeted... Citius Oncology, Inc. concentrates on advancing innovative, targeted therapeutic solutions for various cancer types. A key aspect of its pipeline includes the development of LYMPHIR, an investigational orphan drug intended to treat adults battling cutaneous T-cell lymphoma that has either relapsed or is unresponsive to existing therapies. The firm's main offices are situated in New York, New York. Citius Oncology, Inc. functions as a division of its parent company, Citius Pharmaceuticals, Inc.
Цена акции
$0.7426
Последняя синхронизация: 2026-08-21
Рыночная капитализация
$69.05M
Изменение (1 день)
-2.17%
Изменение (1 год)
-57.57%
Страна
US
Торговля Citius Oncology, Inc. (CTOR)

Категория

История цены акций Citius Oncology, Inc. (CTOR)
Наивысшая цена закрытия: $0.77 2026-08-01

Наименьшая цена закрытия: $11.37 2024-07-01
История цены акций Citius Oncology, Inc. с 2024 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) -4.49%
2025 2.60%
2024 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$1.26K 76.64%
US
$270.77 51.02%
US
$265.40 26.02%
US
$493.69 44.66%
CH
$152.42 74.45%
US